Associate Director, Supply Chain Operations

Redwood City, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in Supply Chain Management, Operations, or a related field, with a minimum of 8 years of experience in supply chain operations, preferably within the biotechnology or pharmaceutical industry. Strong leadership and strategic planning skills are required, along with experience in clinical supply chain management and a thorough understanding of GMP regulations.

Responsibilities

As the Associate Director, Supply Chain Operations, you will own the development and management of Arcellx’s clinical supply chain, including strategic planning, demand forecasting, inventory management, and production scheduling. You will oversee all operational aspects of the clinical supply chain, review clinical protocols, configure IRT systems, develop SOPs, solve technical and business issues, and ensure compliance with GMP regulations. Furthermore, you will build and maintain strong vendor partnerships, negotiate contracts, and drive continuous improvement in vendor performance.

Skills

Supply Chain Management

Clinical Supply Chain

Cell Therapy

Biotechnology

Clinical Development

Operations

Manufacturing

Quality Assurance (QA)

Regulatory Affairs

Clinical Trial Materials (CTM)

Cross-functional Collaboration

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters

2014Year Founded

$194.5MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Fully-Paid Parental Leave

Tuition Reimbursement

Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.

Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.

Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.

The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.

ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.

Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.

Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI

Try Jobo Free